Researchers identify new biomarker and therapeutic target for pancreatic cancer
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention.
Van Andel Research Institute scientists have developed a new tool that can detect pancreatic cancer much more effectively than current tests.